Published in Blood on June 30, 2008
Novel Mechanisms and Approaches to Treat Neonatal Sepsis | NCT02554630
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns | NCT03291496
Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood (2009) 3.90
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) (2010) 2.26
Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity (2012) 2.08
The host response to sepsis and developmental impact. Pediatrics (2010) 1.62
Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin Immunol (2009) 1.59
The influence of developmental age on the early transcriptomic response of children with septic shock. Mol Med (2011) 1.57
Neutrophil and endothelial adhesive function during human fetal ontogeny. J Leukoc Biol (2012) 1.52
Maternal vaccination: moving the science forward. Hum Reprod Update (2014) 1.50
Adverse Events After Routine Immunization of Extremely Low-Birth-Weight Infants. JAMA Pediatr (2015) 1.43
Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol (2010) 1.39
Genome-wide expression profiling in pediatric septic shock. Pediatr Res (2013) 1.39
Ontogeny of early life immunity. Trends Immunol (2014) 1.35
Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis. J Immunol (2013) 1.23
Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling. J Immunol (2011) 1.21
The developing human preterm neonatal immune system: a case for more research in this area. Clin Immunol (2012) 1.17
Pathophysiology and treatment of septic shock in neonates. Clin Perinatol (2010) 1.17
Role of innate immunity in neonatal infection. Am J Perinatol (2013) 1.16
The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection. Infect Immun (2011) 1.13
Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis. Infect Immun (2011) 1.11
Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms. Clin Infect Dis (2013) 1.11
Protective immunity and defects in the neonatal and elderly immune response to sepsis. J Immunol (2014) 1.01
Interleukin 27 as a sepsis diagnostic biomarker in critically ill adults. Shock (2013) 0.98
Innate immune memory: implications for development of pediatric immunomodulatory agents and adjuvanted vaccines. Pediatr Res (2013) 0.96
Neonatal immune adaptation of the gut and its role during infections. Clin Dev Immunol (2013) 0.95
Soluble ecto-5'-nucleotidase (5'-NT), alkaline phosphatase, and adenosine deaminase (ADA1) activities in neonatal blood favor elevated extracellular adenosine. J Biol Chem (2013) 0.95
Early sepsis does not increase the risk of late sepsis in very low birth weight neonates. J Pediatr (2013) 0.88
Human neonatal peripheral blood leukocytes demonstrate pathogen-specific coordinate expression of TLR2, TLR4/MD2, and MyD88 during bacterial infection in vivo. Pediatr Res (2010) 0.88
Enterocolitis causes profound lymphoid depletion in endothelin receptor B- and endothelin 3-null mouse models of Hirschsprung-associated enterocolitis. Eur J Immunol (2015) 0.87
Toll-like receptor 1/2 stimulation induces elevated interleukin-8 secretion in polymorphonuclear leukocytes isolated from preterm and term newborn infants. Neonatology (2011) 0.86
Prophylactic zinc supplementation reduces bacterial load and improves survival in a murine model of sepsis. Pediatr Crit Care Med (2012) 0.85
Arginine depletion increases susceptibility to serious infections in preterm newborns. Pediatr Res (2014) 0.85
Could Biomarkers Direct Therapy for the Septic Patient? J Pharmacol Exp Ther (2016) 0.84
Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis. Infect Immun (2013) 0.84
A neonatal model of intravenous Staphylococcus epidermidis infection in mice <24 h old enables characterization of early innate immune responses. PLoS One (2012) 0.84
A prime time for trained immunity: innate immune memory in newborns and infants. Neonatology (2013) 0.84
Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults. J Crit Care (2014) 0.83
Neonatal host defense against Staphylococcal infections. Clin Dev Immunol (2013) 0.83
Cellular and molecular mechanisms underlying the strong neonatal IL-12 response of lamb mesenteric lymph node cells to R-848. PLoS One (2010) 0.83
Stimulation of TLR7 prior to polymicrobial sepsis improves the immune control of the inflammatory response in adult mice. Inflamm Res (2010) 0.82
Cardiac function and circulating cytokines after endotoxin exposure in neonatal mice. Pediatr Res (2010) 0.81
Neonatal CD71+ Erythroid Cells Do Not Modify Murine Sepsis Mortality. J Immunol (2015) 0.81
Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18. Proc Natl Acad Sci U S A (2016) 0.81
Challenges in vaccination of neonates, infants and young children. Vaccine (2014) 0.80
Very low birth weight neonates who survive early-onset sepsis do not have an increased risk of developing late-onset sepsis. Early Hum Dev (2012) 0.80
Delayed emergency myelopoiesis following polymicrobial sepsis in neonates. Innate Immun (2014) 0.80
Harnessing the beneficial heterologous effects of vaccination. Nat Rev Immunol (2016) 0.79
An Immunological Perspective on Neonatal Sepsis. Trends Mol Med (2016) 0.79
CD4+ T cells are not essential for control of early acute Cryptosporidium parvum infection in neonatal mice. Infect Immun (2011) 0.79
TRIF-dependent innate immune activation is critical for survival to neonatal gram-negative sepsis. J Immunol (2014) 0.78
Postnatal development of hepatic innate immune response. Inflammation (2011) 0.78
Improved emergency myelopoiesis and survival in neonatal sepsis by caspase-1/11 ablation. Immunology (2015) 0.77
Impaired neonatal macrophage phagocytosis is not explained by overproduction of prostaglandin E2. Respir Res (2011) 0.77
Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease. Front Immunol (2017) 0.76
Toll-Like Receptor 4 Agonistic Antibody Promotes Host Defense against Chronic Pseudomonas aeruginosa Lung Infection in Mice. Infect Immun (2016) 0.76
Ready to benefit from training: heterologous effects of early life immunization. Trans R Soc Trop Med Hyg (2015) 0.76
An impaired inflammatory cytokine response to gram-negative LPS in human neonates is associated with the defective TLR-mediated signaling pathway. J Clin Immunol (2015) 0.76
Matrix Metalloproteinase-8 Augments Bacterial Clearance in a Juvenile Sepsis Model. Mol Med (2016) 0.75
Immunological Defects in Neonatal Sepsis and Potential Therapeutic Approaches. Front Pediatr (2017) 0.75
Immunization of pregnant women: Future of early infant protection. Hum Vaccin Immunother (2015) 0.75
LPS Stimulation of Cord Blood Reveals a Newborn-Specific Neutrophil Transcriptomic Response and Cytokine Production. Shock (2017) 0.75
Treatment with milk fat globule epidermal growth factor-factor 8 (MFG-E8) reduces inflammation and lung injury in neonatal sepsis. Surgery (2017) 0.75
Neurological consequences of systemic inflammation in the premature neonate. Neural Regen Res (2017) 0.75
Pathogen recognition and innate immunity. Cell (2006) 44.14
The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30
4 million neonatal deaths: when? Where? Why? Lancet (2005) 28.92
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science (2004) 14.80
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol (2002) 13.10
Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature (2007) 7.34
Control of B-cell responses by Toll-like receptors. Nature (2005) 6.44
MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med (2007) 5.48
Neonatal adaptive immunity comes of age. Nat Rev Immunol (2004) 5.31
Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol (2007) 5.20
Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med (1997) 5.19
Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol (2001) 4.49
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med (2007) 4.39
Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med (2004) 4.34
Necrotising enterocolitis. Lancet (2006) 3.94
Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat Immunol (2002) 3.75
Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest (1991) 3.62
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol (2000) 3.58
Adaptive immune cells temper initial innate responses. Nat Med (2007) 3.37
A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med (1998) 3.32
Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol (1999) 2.92
Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med (2005) 2.53
Toll-like receptors induce a phagocytic gene program through p38. J Exp Med (2003) 2.49
TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J Immunol (2007) 2.27
Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol (2002) 2.25
Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J Immunol (1998) 2.01
Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses. J Immunol (2003) 1.82
Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med (2006) 1.78
Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J Immunol (2002) 1.70
Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol (2002) 1.66
Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood (2006) 1.65
Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides. J Immunol (2006) 1.63
Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics (2004) 1.60
Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J Immunol (2007) 1.52
Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock (2007) 1.50
Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med (2007) 1.39
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood (2007) 1.29
T cell activation by TLRs: a role for TLRs in the adaptive immune response. Sci STKE (2007) 1.28
Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J Immunol (2000) 1.26
Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J Immunol (2006) 1.18
Imiquimod and resiquimod as novel immunomodulators. J Antimicrob Chemother (2001) 1.10
CpG oligodeoxynucleotides enhance neonatal resistance to Listeria infection. J Immunol (2005) 1.08
CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus. J Immunol (2006) 1.06
Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation. Int Immunol (2005) 1.00
Activation of common antiviral pathways can potentiate inflammatory responses to septic shock. Shock (2006) 0.88
Effect of a novel topical immunomodulator, S-28463, on keratinocyte cytokine gene expression and production. J Interferon Cytokine Res (1996) 0.87
Sepsis in neonates and children: definitions, epidemiology, and outcome. Pediatr Emerg Care (1997) 0.85
Neonatal T cell function. J Pediatr Gastroenterol Nutr (2005) 0.84
Lymphocyte subpopulations in full-term septic neonates. Pediatr Int (1999) 0.79
Interleukin 6 as early mediator in neonatal sepsis. Pediatr Infect Dis J (1992) 0.78
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
A network-based analysis of systemic inflammation in humans. Nature (2005) 12.60
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med (2007) 5.48
Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A (2005) 3.49
Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics (2004) 3.22
Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med (2007) 2.85
Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics (2005) 2.50
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science (2013) 2.34
Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med (2003) 2.30
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) (2010) 2.26
High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics (2006) 2.25
Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg (2012) 2.24
Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov (2003) 2.18
Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol (2011) 2.17
The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock. Crit Care Med (2012) 2.17
Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity (2012) 2.08
Benchmarking outcomes in the critically injured trauma patient and the effect of implementing standard operating procedures. Ann Surg (2012) 2.07
A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med (2010) 2.06
TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. J Immunol (2006) 2.05
Clinical microfluidics for neutrophil genomics and proteomics. Nat Med (2010) 2.02
Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci U S A (2002) 2.01
B cells enhance early innate immune responses during bacterial sepsis. J Exp Med (2011) 1.99
TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med (2008) 1.99
Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics (2005) 1.94
Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients. Crit Care Med (2013) 1.94
Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol (2006) 1.86
Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways. Proc Natl Acad Sci U S A (2006) 1.82
Neonatal babesiosis: case report and review of the literature. Pediatr Infect Dis J (2006) 1.78
Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med (2002) 1.78
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc Natl Acad Sci U S A (2009) 1.77
Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun (2003) 1.75
Impaired autophagy: A mechanism of mitochondrial dysfunction in anoxic rat hepatocytes. Hepatology (2008) 1.73
CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis. J Immunol (2005) 1.71
Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock (2005) 1.71
Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis. Crit Care Med (2007) 1.63
A better understanding of why murine models of trauma do not recapitulate the human syndrome. Crit Care Med (2014) 1.62
Human transcriptome array for high-throughput clinical studies. Proc Natl Acad Sci U S A (2011) 1.62
Continuous flow microfluidic device for rapid erythrocyte lysis. Anal Chem (2004) 1.61
Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr Res (2006) 1.59
CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14). Crit Care Med (2004) 1.58
Role of Toll-like receptors in the development of sepsis. Shock (2008) 1.57
Neck injury and fibromyalgia-- are they really associated? J Rheumatol (2006) 1.56
Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. J Immunol (2010) 1.54
A novel type I IFN-producing cell subset in murine lupus. J Immunol (2008) 1.50
Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock (2007) 1.50
Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10. J Exp Med (2010) 1.50
A genomic score prognostic of outcome in trauma patients. Mol Med (2009) 1.48
Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J Allergy Clin Immunol (2004) 1.43
Aberrant signaling in the TNFalpha/TNF receptor 1 pathway of the NZM2410 lupus-prone mouse. Clin Immunol (2004) 1.41
Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol (2010) 1.39
Management of first-time dislocations of the shoulder in patients older than 40 years: the prevalence of iatrogenic fracture. J Orthop Trauma (2013) 1.39
Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis. J Immunol (2004) 1.36
Analysis of factorial time-course microarrays with application to a clinical study of burn injury. Proc Natl Acad Sci U S A (2010) 1.33
Developmental biology of the innate immune response: implications for neonatal and infant vaccine development. Pediatr Res (2009) 1.33
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood (2007) 1.29
Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev (2005) 1.28
Incidence, clinical predictors, genomics, and outcome of acute kidney injury among trauma patients. Ann Surg (2010) 1.27
Cost and Mortality Associated With Postoperative Acute Kidney Injury. Ann Surg (2015) 1.26
Large-scale multiplexed quantitative discovery proteomics enabled by the use of an (18)O-labeled "universal" reference sample. J Proteome Res (2009) 1.24
Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J Immunol (2003) 1.23
Preclinical models of shock and sepsis: what can they tell us? Shock (2005) 1.23
The origins of cachexia in acute and chronic inflammatory diseases. Nutr Clin Pract (2006) 1.23
Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One (2011) 1.22
Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling. J Immunol (2011) 1.21
Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation (2002) 1.19
Safety and efficacy of neonatal vaccination. Eur J Immunol (2009) 1.17
Role of innate immunity in neonatal infection. Am J Perinatol (2013) 1.16
Parallels between cancer and infectious disease. N Engl J Med (2014) 1.16
Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit Care Med (2005) 1.16
"Endogenous adjuvant" activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60. Arthritis Rheum (2006) 1.14
Biology of tumor necrosis factor-alpha- implications for psoriasis. Exp Dermatol (2004) 1.14